Latest issue of Clinical laboratory
March 2026
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
PromoCell launches GMP cell culture media services for clinical therapy applications
, /in E-News /by panglobalPromoCell GmbH, the Heidelberg-based manufacturer of primary human cells and specialised cell culture media, has announced its entry into the Good Manufacturing Practice (GMP) arena with a new service portfolio designed for cell-based therapy and regenerative medicine applications. The company debuted its Custom GMP Cell Culture Media Services at the 32nd European Society of Gene […]
BioMed X establishes women’s health research accelerator in Heidelberg
, /in E-News /by panglobalBioMed X has launched XFem Labs, a dedicated women’s health research and development accelerator at its Heidelberg facility, marking a strategic expansion of the institute’s translational research portfolio. The initiative, backed by a $2 million grant from the Gates Foundation, will focus on addressing critical gaps in women’s healthcare, with particular emphasis on accessible contraceptive […]
Extended Chromsystems Assay for Newborn Screening now Available
, /in Product News /by panglobalChromsystems, experts in the development and manufacture of high-quality diagnostic products based on high-performance liquid chromatography (HPLC) and tandem mass spectrometry (LC-MS/MS), announces the release of the MassScreen® Amino Acids, Acylcarnitines EXTENDED from Dried Blood non-derivatised.
Retinol-Binding Protein (RBP) assays, for serum and urine, for Optilite®, IMMAGE® and other Clinical Chemistry analyzers
, /in Product News /by panglobalTRIMERO Diagnostics offers IVD CE marked Retinol Binding Protein (RBP, RBP4) assays, for serum and urine samples.
Improved approach for managing diabetic ketoacidosis (DKA) with DiaSys Hydroxybutyrate 21 FS
, /in Product News /by panglobalDiaSys β-Hydroxybutyrate 21 FS represents a significant advancement in managing diabetic ketoacidosis (DKA), a serious and potentially life-threatening complication of diabetes.
Clinical Laboratory
, /in Advertenties /by panglobalThe leading international source for Clinical laboratory Equipment
Nova biomedical | Advanced Test Menu for Critical Care
, /in Advertenties /by panglobalThe Modern Critical Care Profile
β-Hydroxybutyrate 21 FS
, /in Advertenties /by panglobalFirst choice for reliable ketosis management
HIT Testing in Minutes
, /in Advertenties /by panglobalThe on-demand solution that saves more than time
New high-throughput platform accelerates antibody testing for disease research
, /in E-News /by panglobalUniversity of Illinois researchers have developed oPool+ display, a breakthrough method that enables researchers to construct and test hundreds of antibodies in parallel rather than individually. The platform dramatically reduces costs and time for antibody discovery across multiple diseases, with the aim of transforming therapeutic development for cancer, infectious diseases, and autoimmune conditions.